{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T17:22:34Z","timestamp":1762622554194,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ijcha.2025.101737","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T18:11:30Z","timestamp":1751566290000},"page":"101737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Myocardial-to-background ratio in F18-fluorodeoxyglucose PET in cardiac sarcoidosis for diagnosis and evaluation of therapeutic response"],"prefix":"10.1016","volume":"59","author":[{"given":"Laura","family":"Ueberham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Kluge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konrad","family":"Latuscynski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Ebbinghaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Jozwiak-Nozdrzykowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Renziehausen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annika","family":"Reuser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Bode","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regine","family":"Kluge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Laufs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osama","family":"Sabri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borislav","family":"Dinov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcha.2025.101737_b0005","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1093\/eurheartj\/ehae356","article-title":"Management of cardiac sarcoidosis","volume":"45","author":"Sharma","year":"2024","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcha.2025.101737_b0010","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.007030","article-title":"Complementary value of cardiac magnetic resonance imaging and positron emission tomography\/computed tomography in the assessment of cardiac sarcoidosis","volume":"11","author":"Vita","year":"2018","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcha.2025.101737_b0015","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","article-title":"JCS 2016 Guideline on diagnosis and treatment of cardiac sarcoidosis - digest version","volume":"83","author":"Terasaki","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.ijcha.2025.101737_b0020","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1067\/j.cpradiol.2018.02.002","article-title":"Pitfalls and misinterpretations of cardiac findings on PET\/CT Imaging: a careful look at the heart in oncology patients","volume":"48","author":"Betancourt Cuellar","year":"2019","journal-title":"Curr. Probl. Diagn. Radiol."},{"key":"10.1016\/j.ijcha.2025.101737_b0025","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.2967\/jnumed.107.041574","article-title":"Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET\/CT","volume":"48","author":"Inglese","year":"2007","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ijcha.2025.101737_b0030","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.118.008975","article-title":"Diagnostic accuracy of advanced imaging in cardiac sarcoidosis","volume":"12","author":"Divakaran","year":"2019","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcha.2025.101737_b0035","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s12350-018-01582-y","article-title":"Diagnostic performance of F-18 FDG PET for detection of cardiac sarcoidosis; a systematic review and meta-analysis","volume":"27","author":"Kim","year":"2020","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.ijcha.2025.101737_b0040","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2967\/jnmt.119.233353","article-title":"Revisiting weight-normalized SUV and lean-body-mass-normalized SUV in PET studies","volume":"48","author":"Sarikaya","year":"2020","journal-title":"J. Nucl. Med. Technol."},{"key":"10.1016\/j.ijcha.2025.101737_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmp.2023.102584","article-title":"Impact of patient's habitus on image quality and quantitative metrics in 18F-FDG PET\/CT images","volume":"109","author":"Zorz","year":"2023","journal-title":"Phys. Med."},{"key":"10.1016\/j.ijcha.2025.101737_b0050","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1007\/s00259-020-05066-5","article-title":"Procedural recommendations of cardiac PET\/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation (4Is)-related cardiovascular diseases: a joint collaboration of the EACVI and the EANM","volume":"48","author":"Slart","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ijcha.2025.101737_b0055","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13550-018-0447-8","article-title":"Which is the proper reference tissue for measuring the change in FDG PET metabolic volume of cardiac sarcoidosis before and after steroid therapy?","volume":"8","author":"Furuya","year":"2018","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.ijcha.2025.101737_b0060","doi-asserted-by":"crossref","DOI":"10.1161\/HCI.0000000000000081","article-title":"State-of-the-art imaging of infiltrative cardiomyopathies: a scientific statement from the American Heart Association","volume":"16","author":"Kottam","year":"2023","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcha.2025.101737_b0065","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and detection of sarcoidosis. an official American thoracic society clinical practice guideline","volume":"201","author":"Crouser","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ijcha.2025.101737_b0070","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcha.2025.101737_b0075","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s12350-017-1122-6","article-title":"Volume-based glucose metabolic analysis of FDG PET\/CT: the optimum threshold and conditions to suppress physiological myocardial uptake","volume":"26","author":"Manabe","year":"2019","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.ijcha.2025.101737_b0080","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/2191-219X-3-77","article-title":"The PET-derived tumor-to-blood standard uptake ratio (SUR) is superior to tumor SUV as a surrogate parameter of the metabolic rate of FDG","volume":"3","author":"van den Hoff","year":"2013","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.ijcha.2025.101737_b0085","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.2967\/jnumed.117.190736","article-title":"Test-retest variability in lesion SUV and lesion SUR in 18F-FDG PET: an analysis of data from two prospective multicenter trials","volume":"58","author":"Hofheinz","year":"2017","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ijcha.2025.101737_b0090","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s12350-014-9901-9","article-title":"Quantitative interpretation of FDG PET\/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis","volume":"21","author":"Ahmadian","year":"2014","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.ijcha.2025.101737_b0095","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12350-016-0490-7","article-title":"The response of FDG uptake to immunosuppressive treatment on FDG PET\/CT imaging for cardiac sarcoidosis","volume":"24","author":"Ahmadian","year":"2017","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.ijcha.2025.101737_b0100","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12350-019-01659-2","article-title":"FDG-PET in possible cardiac sarcoidosis: right ventricular uptake and high total cardiac metabolic activity predict cardiovascular events","volume":"28","author":"Tuominen","year":"2021","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.ijcha.2025.101737_b0105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1286684","article-title":"Assessment of treatment response in cardiac sarcoidosis based on myocardial 18F-FDG uptake","volume":"14","author":"Frischknecht","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijcha.2025.101737_b0110","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/ejhf.3057","article-title":"Predictors of outcome in a contemporary cardiac sarcoidosis population: Role of brain natriuretic peptide, left ventricular function and myocardial inflammation","volume":"25","author":"Kouranos","year":"2023","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcha.2025.101737_b0115","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s12350-019-01916-4","article-title":"The rate of myocardial perfusion recovery after steroid therapy and its implication for cardiac events in cardiac sarcoidosis and primarily preserved left ventricular ejection fraction","volume":"28","author":"Koyanagawa","year":"2021","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.ijcha.2025.101737_b0120","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/CIRCIMAGING.112.000289","article-title":"Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by 18F- fluorodoexyglucose positron emission tomography?","volume":"6","author":"Mc Ardle","year":"2013","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcha.2025.101737_b0125","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1007\/s12350-018-01504-y","article-title":"The prognostic value of quantitating and localizing F-18 FDG uptake in cardiac sarcoidosis","volume":"27","author":"Flores","year":"2020","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.ijcha.2025.101737_b0130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12872-019-01323-0","article-title":"Diagnostic and predictive value of speckle tracking echocardiography in cardiac sarcoidosis","volume":"20","author":"Di Stefano","year":"2020","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.ijcha.2025.101737_b0135","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s10741-021-10156-z","article-title":"Multiple roles of cardiac macrophages in heart homeostasis and failure","volume":"27","author":"Moskalik","year":"2022","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.ijcha.2025.101737_b0140","doi-asserted-by":"crossref","DOI":"10.1148\/ryct.2020190140","article-title":"Utility of FDG PET and cardiac MRI in diagnosis and monitoring of immunosuppressive treatment in cardiac sarcoidosis","volume":"2","author":"Coulden","year":"2020","journal-title":"Radiol. Cardiothorac. Imaging"},{"key":"10.1016\/j.ijcha.2025.101737_b0145","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1007\/s00259-018-4001-8","article-title":"Prognostic role of serial quantitative evaluation of 18F-fluorodeoxyglucose uptake by PET\/CT in patients with cardiac sarcoidosis presenting with ventricular tachycardia","volume":"45","author":"Muser","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ijcha.2025.101737_b0150","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","article-title":"Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis","volume":"21","author":"Osborne","year":"2014","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.ijcha.2025.101737_b0155","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s12350-021-02567-0","article-title":"Prognosis and recurrence in cardiac sarcoidosis: Serial assessment of BMIPP SPECT and FDG-PET","volume":"28","author":"Yamamoto","year":"2021","journal-title":"J. Nucl. Cardiol."}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235290672500140X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235290672500140X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T17:18:29Z","timestamp":1762622309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235290672500140X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":31,"alternative-id":["S235290672500140X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2025.101737","relation":{},"ISSN":["2352-9067"],"issn-type":[{"type":"print","value":"2352-9067"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myocardial-to-background ratio in F18-fluorodeoxyglucose PET in cardiac sarcoidosis for diagnosis and evaluation of therapeutic response","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2025.101737","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101737"}}